A detailed history of Met Life Investment Management, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,445 shares of EMBC stock, worth $380,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,445
Holding current value
$380,562
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$12.35 - $19.33 $375,995 - $588,501
30,445 New
30,445 $404,000
Q2 2023

Apr 29, 2024

BUY
$21.6 - $30.69 $657,612 - $934,357
30,445 New
30,445 $657,000
Q1 2023

May 09, 2024

BUY
$23.07 - $32.77 $702,366 - $997,682
30,445 New
30,445 $856 Million
Q2 2022

May 10, 2024

BUY
$24.78 - $33.36 $754,427 - $1.02 Million
30,445 New
30,445 $770,000
Q2 2022

Aug 11, 2022

BUY
$24.78 - $33.36 $754,427 - $1.02 Million
30,445 New
30,445 $771,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $723M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.